| 1 |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015, 65(2): 87-108.
|
| 2 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 3 |
de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection [J]. Best Pract Res Clin Obstet Gynaecol, 2018, 47: 2-13.
|
| 4 |
Shi R, Devarakonda S, Liu LH, et al. Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007-2010 [J]. BMC Res Notes, 2014, 7: 544.
|
| 5 |
Rudolph SE, Lorincz A, Wheeler CM, et al. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico [J]. BMC Infect Dis, 2016, 16: 461.
|
| 6 |
Cao D, Zhang SH, Zhang Q, et al. Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: A hospital-based investigation [J]. J Med Virol, 2017, 89(7): 1281-1286.
|
| 7 |
Delory T, Ngo-Giang-Huong N, Rangdaeng S, et al. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand [J]. J Infect, 2017, 74(5): 501-511.
|
| 8 |
Castellsagué X, Díaz M, Vaccarella S, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies [J]. Lancet Oncol, 2011, 12(11): 1023-1031.
|
| 9 |
Banister CE, Messersmith AR, Cai B, et al. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age [J]. J Infect Dis, 2015, 211(1): 100-108.
|
| 10 |
Rettig EM, Fakhry C, Rositch AF, et al. Race is Associated With Sexual Behaviors and Modifies the Effect of Age on Human Papillomavirus Serostatus Among Perimenopausal Women [J]. Sex Transm Dis, 2016, 43(4): 231-237.
|
| 11 |
Wang XH, Ji YP, Li J, et al. Prevalence of human papillomavirus infection in women in the Autonomous Region of Inner Mongolia: A population-based study of a Chinese ethnic minority [J]. J Med Virol, 2018, 90(1): 148-156.
|
| 12 |
Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study [J]. Br J Cancer, 2006, 95(1): 96-101.
|
| 13 |
Baloch Z, Yasmeen N, Li Y, et al. Prevalence and risk factors for human papillomavirus infection among Chinese ethnic women in southern of Yunnan, China [J]. Braz J Infect Dis, 2017, 21(3): 325-332.
|
| 14 |
Baloch Z, Yuan T, Wang B, et al. Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan, China [J]. J Med Virol, 2016, 88(3): 532-540.
|
| 15 |
Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People′s Republic of China: a population-based study [J]. Br J Cancer, 2009, 101(9): 1635-1640.
|
| 16 |
Eldridge RC, Pawlita M, Wilson L, et al. Smoking and subsequent human papillomavirus infection: a mediation analysis [J]. Ann Epidemiol, 2017, 27(11): 724-730. e1.
|
| 17 |
Wilson LE, Pawlita M, Castle PE, et al. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study [J]. Int J Cancer, 2013, 133(9): 2172-2181.
|
| 18 |
Rudolph SE, Lorincz A, Wheeler CM, et al. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico [J]. BMC Infect Dis, 2016, 16: 461.
|
| 19 |
Okunade KS, Nwogu CM, Oluwole AA, et al. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria [J]. Pan Afr Med J, 2017, 28: 227.
|
| 20 |
Catarino R, Vassilakos P, Tebeu PM, et al. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women [J]. Cancer Epidemiol, 2016, 40: 60-66.
|
| 21 |
Lekovich J, Amrane S, Pangasa M, et al. Comparison of Human Papillomavirus infection and cervical cytology in women using copper-containing levonorgestrel-containing intrauterine devices [J]. Obstet Gynecol, 2015, 125(5): 1101-1105.
|
| 22 |
Alhamlan FS, Khayat HH, Ramisetty-MS, et al. Sociodemographic characteristics and sexual behavior as risk factors for human papillomavirus infection in Saudi Arabia [J]. Int J Infect Dis, 2016, 46: 94-99.
|
| 23 |
Marks M, Gravitt PE, Gupta SB, et al. Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand [J]. J Infect Dis, 2011, 204(10): 1505-1513.
|
| 24 |
Sasieni P. Cervical cancer prevention and hormonal contraception [J]. Lancet, 2007, 370(9599): 1591-1592.
|
| 25 |
Hapgood JP, Kaushic C, Hel Z. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms [J]. Endocr Rev, 2018, 39(1): 36-78.
|
| 26 |
张旭梅，李芹，柳露, 等. 阴道微生态与高危型HPV感染和宫颈病变的关系 [J]. 中国妇幼保健, 2018, 33(8): 1739-1741.
|
| 27 |
Lee JE, Lee Se, Lee H, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort [J]. PLoS One, 2013, 8(5): e63514.
|
| 28 |
Brotman RM, Shardell MD, Gajer P, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection [J]. J Infect Dis, 2014, 210(11): 1723-1733.
|
| 29 |
Gajer P, Brotman RM, Bai G, et al. Temporal dynamics of the human vaginal microbiota [J]. Sci Transl Med, 2012, 4(132): 132ra52.
|
| 30 |
Mitra A, MacIntyre DA, Lee YS, et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity [J]. Sci Rep, 2015, 5: 16865.
|
| 31 |
刘彤，唐立，工林美, 等. 乳酸杆菌发酵滤液对人宫颈癌细胞株Hela细胞的抑制作用 [J]. 中国微生态学杂志, 2009, 21(9): 773-775.
|
| 32 |
Liu SH, Chen HJ, Hsieh TH, et al. Excessive adiposity, metabolic health, and risks for genital human papillomavirus infection in adult women: a population-based cross-sectional study [J]. BMC Obes, 2015, 2: 39.
|
| 33 |
Huang X, Zhao Q, Yang PT, et al. Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection [J]. Medicine(Baltimore), 2016, 95(9): e2905.
|
| 34 |
Molokwu JC, Penaranda E, Lopez DS, et al. Association of Metabolic Syndrome and Human Papillomavirus Infection in Men and Women Residing in the United States [J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(8): 1321-1327.
|
| 35 |
Mendoza-Pinto C, Garcia-Carrasco M, Vallejo-Ruiz V, et al. The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus [J]. Clinics(Sao Paulo), 2013, 68(12): 1475-1480.
|
| 36 |
Yu SL, Chan PK, Wong CK, et al. Antagonist-mediated down-regulation of toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus [J]. Arthritis Res Ther, 2012, 14(2): R80.
|
| 37 |
于水莲，陶怡，黄文辉, 等. Toll样受体7在系统性红斑狼疮合并高危人乳头瘤病毒感染中的作用 [J]. 广东医学, 2016, 37(2): 236-241.
|
| 38 |
Rojo-Contreras W, Olivar-Flores EM, Gamez-Nava JI, et al. Cervical humanpapillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis [J]. Lupus, 2012, 21(4): 365-372.
|
| 39 |
Chih HJ, Lee AH, Colville L, et al. A review of dietary prevention of human papillomavirus-related infection of the cervix and cervical intraepithelial neoplasia [J]. Nutr Cancer, 2013, 65(3): 317-328.
|